| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 02/23/2006 | WO2004074310A3 Mycobacterial diagnostics |
| 02/23/2006 | US20060041108 Renilla reniformis green fluorescent protein |
| 02/23/2006 | US20060041107 Mutants of streptococcal toxin A and methods of use |
| 02/23/2006 | US20060040334 Method for characterising analytes |
| 02/23/2006 | US20060037860 Small separation apparatus |
| 02/23/2006 | CA2574340A1 Immunogenic complexes, preparation method thereof and use of same in pharmaceutical compositions |
| 02/22/2006 | EP1627683A2 Metal chelating compositions |
| 02/22/2006 | EP1627224A1 Differential analysis of cell surface proteins on closed membrane structures by labelling with dyes in the presence of an internal standard |
| 02/22/2006 | EP1627081A2 Use of jag2 expression in diagnosis of plasma cell disorders |
| 02/22/2006 | EP1627062A1 A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire |
| 02/22/2006 | EP1626983A2 Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof |
| 02/22/2006 | EP1626982A2 Metal chelate complexes immobilized on solid supports for peptide preparation |
| 02/22/2006 | EP1626981A2 Dipeptidyl-peptidase protected proteins |
| 02/22/2006 | EP1463750A4 Plant cyclopropane fatty acid synthase genes, proteins and uses thereof |
| 02/22/2006 | EP1322958B1 Selective binding materials |
| 02/22/2006 | EP1047788B1 Method of determining metastatic potential employing the asp1 gene |
| 02/22/2006 | EP0907378B1 Method for the concentration of antibody solutions |
| 02/22/2006 | CN1738835A Process for the purification of TNF-binding proteins using IMAC |
| 02/22/2006 | CN1737149A Directional evolution method using in separating anti-embolism substance, and anti emboism substance and purification method |
| 02/22/2006 | CN1737136A Production method of animal use recombinant interferon |
| 02/22/2006 | CN1736538A Method for enhancing dynamic absorption volume of ion exchange absorbent of transverse electric field |
| 02/22/2006 | CN1736537A Size exclusion chromatography method for separating biomacromolecule of preparation type transverse electric field |
| 02/22/2006 | CN1243095C Extracting process of actinidia proteinase |
| 02/22/2006 | CN1243021C Interleukin-18 binding proteins, their preparation and use |
| 02/22/2006 | CN1243019C Separation and purification process of recombinant human erythrogenin |
| 02/22/2006 | CN1243015C Separating and purifying technology for micro algae phycoerythrin |
| 02/21/2006 | US7001993 site-directed mutagenesis; high protease-inhibitory activity in absence of heparin |
| 02/21/2006 | US7001989 Conjugates comprising two active agents |
| 02/21/2006 | US7001988 Wound healing agents |
| 02/21/2006 | US7001987 Hydrogel with controllable mechanical, chemical, and biological properties and method for making same |
| 02/21/2006 | US7001986 Fluorescent proteins |
| 02/21/2006 | US7001982 Non-natural C-linked carbo-β-peptides with robust secondary structures |
| 02/21/2006 | US7001885 Isolation of biopolymers from human serum albumin; obtain human serum albumin, expose to ion exchange resin, elute and recover biopolymer |
| 02/21/2006 | US7001881 joint-lubricating glycoproteins; polypeptide and O-linked oligosaccharide moiety [B(1-3)Gal-GalNAc]; antiarthritic agent maintains viscosity of synovial fluid; osteoarthritis |
| 02/21/2006 | US7001752 Murine and human kinases |
| 02/21/2006 | US7001729 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 02/21/2006 | US7001550 Charged filtration membranes and uses therefor |
| 02/21/2006 | US7001438 Method for performing submicroliter crystallization experiments with high experiment to experiment precision |
| 02/21/2006 | CA2112450C Cross-linked linear polysaccharide polymers as gels for electrophoresis |
| 02/21/2006 | CA2098959C Compounds and methods for the site-specific photoaffinity labelling of biomolecules |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/16/2006 | WO2006016960A2 Method for purifying a protein of the cystine-knot superfamily |
| 02/16/2006 | WO2005118617A3 Method for the purification of polymers carrying a lipophilic group |
| 02/16/2006 | WO2005103068A3 Methods and kits for folding proteins in the presence of linear or branched sugar polymers |
| 02/16/2006 | WO2004101600A3 Novel poly(ethylene glycol) modified compounds and uses thereof |
| 02/16/2006 | WO2004078777A3 Dipeptidyl-peptidase protected proteins |
| 02/16/2006 | WO2003059248A3 Pigment epithelium derived factor from human plasma and methods of use thereof |
| 02/16/2006 | US20060036081 Process for the preparation of a von Willebrand (FvW) factor concentrate by chromatography and a FvW concentrate thus obtainable |
| 02/16/2006 | US20060036079 Surface protein of Leptospira |
| 02/16/2006 | US20060035839 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/16/2006 | US20060035281 Methods and systems for generating peptides |
| 02/16/2006 | US20060035276 Membrane protein library for proteome analysis and method for preparing same |
| 02/16/2006 | US20060035266 selective transport from an aqueous phase to an oil phase; particle size reversibly increased and decreased by irradiation; filter membrane; biodegradable; azo and an azoxy cis-trans isomers reversibly transformed by UV and light |
| 02/16/2006 | US20060035265 In vitro selection and optional indentification of polypeptides using solid support carriers |
| 02/16/2006 | US20060035232 making in vitro peptide expression libraries and for the isolation of nucleotide sequences encoding peptides of interest; constructing and screening DNA libraries for DNA sequences that encode biologically active molecules |
| 02/16/2006 | CA2575784A1 Use of magnetic material to fractionate samples |
| 02/16/2006 | CA2573368A1 Improved aprotinin variants |
| 02/16/2006 | CA2572947A1 Method for purifying a protein of the cystine-knot superfamily |
| 02/16/2006 | CA2514438A1 Process for the preparation of a von willebrand factor (vwf) concentrate by chromotographic means and vwf prepared thereby |
| 02/15/2006 | EP1625857A2 Conjugates of defined stoichiometry |
| 02/15/2006 | EP1625378A2 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 02/15/2006 | EP1625209A2 Immunoglobulin chimeric monomer-dimer hybrids |
| 02/15/2006 | EP1625151A2 Comparative ligand mapping from mhc class i positive cells |
| 02/15/2006 | EP1625147A1 Method of chromatographic analysis of a protein solution |
| 02/15/2006 | EP1625145A1 Extraction process for a pharmaceutical product |
| 02/15/2006 | EP1624952A2 Pre-cast electrophoresis slab gels with extended storage life |
| 02/15/2006 | EP1624950A1 Process for prefiltration of a protein solution |
| 02/15/2006 | EP0762892B1 Diphtheria toxin vaccines bearing a mutated r domain |
| 02/15/2006 | CN1735687A MK2 interacting proteins |
| 02/15/2006 | CN1733801A Extraction method and uses of traditional Chinese medicine cassia seed protein |
| 02/15/2006 | CN1733797A Thymus gland pentapeptide purification technique |
| 02/15/2006 | CN1733721A Maleimide derivative and its preparation method and uses |
| 02/15/2006 | CN1242062C Method for producing a peptide with a pi above 8 or below 5 |
| 02/15/2006 | CN1242059C Production of rDSPA 'alpha' I |
| 02/15/2006 | CN1241943C Method for extracting insulin-like growth factor (IGF-1) from fresh antler |
| 02/15/2006 | CN1241938C Purification technique in preparing genetic engineering vaccine of heat shock protein A of recombined Helicobacter pylori |
| 02/15/2006 | CN1241935C Liquid phase sgnthesis method of thymus pentapeptide |
| 02/14/2006 | US6998470 by using diafiltration, solid phase extraction and immunoaffinity techniques |
| 02/14/2006 | US6998466 flax meal is added to an aqueous acidic solution to form a first mixture having a solid fraction and an aqueous fraction containing water soluble-carbohydrates, mixture is separated and the solid fraction is then hydrolyzed using a lipolytic enzyme |
| 02/14/2006 | US6998229 Used to control expression of a transgene, detect glucuronides in a sample, and isolate glucuronides from a sample |
| 02/14/2006 | US6998123 interleukins (IL-11); fibronectins; glycoproteins |
| 02/14/2006 | CA2336597C Hepatitis c inhibitor peptides |
| 02/14/2006 | CA2247889C Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 02/14/2006 | CA1341497C Biologically active fragments of human antihemophilic factor and method for preparation thereof |
| 02/14/2006 | CA1341496C Production of thrombin inhibitors |
| 02/09/2006 | WO2004009616A3 Ghrelin analogs |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060030696 Protein a chromatography |
| 02/09/2006 | US20060030521 Remodeling and glycoconjugation of peptides |
| 02/09/2006 | US20060030055 Methods and kits for separation and detection of proteins in biological samples |
| 02/09/2006 | US20060030007 Peptides for metal ion affinity chromatography |
| 02/09/2006 | US20060029984 PSP94 diagnostic reagents and assays |
| 02/09/2006 | US20060029966 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/09/2006 | US20060029946 Live cell biosensors |
| 02/09/2006 | US20060029547 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders |
| 02/09/2006 | US20060029545 Metal radionuclide complexed directly to a an annexin that has been modified to add a sulfhydryl group which participates in the complexation of the metal radionuclide; useful for imaging vascular thrombi |
| 02/09/2006 | US20060027455 Selective detection of proteins that contain two or more alpha-helical transmembrane domains |
| 02/09/2006 | US20060027454 Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis |
| 02/08/2006 | EP1623994A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 02/08/2006 | EP1623988A1 Protein refolding apparatus and method of using the same |